Coeptis Therapeutics Holdings Inc — Quarterly Cash Flow (NASDAQ:COEP)

Financials

Total assets 8.91 M13.45 M12.19 M14.18 M16.15 M Total liabilities 5.04 M5.99 M5.11 M3.26 M2.09 M Total equity 3.87 M7.46 M7.08 M10.92 M14.07 M Total liabilities & shareholders' equities 8.91 M13.45 M12.19 M14.18 M16.15 M Total debt 1.34 M1.99 M1.29 M250 K250 K Net debt 804.99 K1.99 M301.44 K-171.7 K-5.85 M

COEP

Financials

뉴스

코에프티스 테라퓨틱스, 나스닥으로부터 연례 회의 지연 통지 받아

Coeptis Therapeutics receives Nasdaq notice for delayed annual meeting

Coeptis Therapeutics extinguishes convertible debt with Yorkville

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

SNAP Biosciences licenses Monarch’s cell therapy tech

Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss - Coursera (NYSE:COUR), Coeptis Therapeutics (NASDAQ:COEP)

Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results - Azul (NYSE:AZUL), AGM Gr Hldgs (NASDAQ:AGMH)